Stay updated with breaking news from Risk Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA is evaluating reports of side effects such as hair loss and suicidal thoughts in people taking medications like Ozempic, Mounjaro and Wegovy.
The FDA is evaluating reports of side effects such as hair loss and suicidal thoughts in people taking drugs like Ozempic, Mounjaro and Wegovy.
These drugs, known as GLP-1 receptor agonists, are approved to treat diabetes or weight loss.
The FDA is evaluating reports of side effects such as hair loss and suicidal thoughts in people taking medications like Ozempic, Mounjaro and Wegovy.
(CNN) — The US Food and Drug Administration is evaluating reports of side effects such as hair loss and suicidal thoughts in people taking medications like Ozempic, Mounjaro and Wegovy.